Cindunistat
Cindunistat (SD-6010) is a potent, orally active and selective iNOS inhibitor[1].
Product Specifications
CAS Number
[364067-22-1]
Product Name Alternative
SD-6010
UNSPSC
12352211
Hazard Statement
H302-H315-H319-H335
Target
NO Synthase
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cindunistat.html
Smiles
CC(NCCSC[C@](C)(N)C(O)=O)=N
Molecular Formula
C8H17N3O2S
Molecular Weight
219.30
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Hellio le Graverand MP, et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2013;72 (2) :187-195.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6462697-01 0.1 mL
AMPK1 (Ser487) (5'-AMP-activated Protein Kinase, Catalytic Subunit alpha-1 Chain, AMPK Subunit alpha-1, PRKAA1) (MaxLight 650)
Ask
View Details MBS6462697-02 5x 0.1 mL
AMPK1 (Ser487) (5'-AMP-activated Protein Kinase, Catalytic Subunit alpha-1 Chain, AMPK Subunit alpha-1, PRKAA1) (MaxLight 650)
Ask
View Details 
130413-APC 100 µL
NALP2 (NACHT, LRR and PYD Domains-containing Protein 2, Nucleotide-binding site Protein 1, PYRIN Domain and NACHT Domain-containing Protein 1, PYRIN-containing APAF1-like Protein 2, NLRP2, NBS1, PAN1, PYPAF2, CLR19.9, FLJ20510) (APC)
Ask
View Details NBP3-08244AF350 100 µL
Rabbit Monoclonal CD43/Sialophorin Antibody (SPN/2049R) [Alexa Fluor 350]
Ask
View Details